Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Prospective On-site and Questionnaire Study for the FOLLOW-UP of Mpox Cohort at ITM PLUS Evaluation of the Longevity of B- and T-cell Immune Responses in Former Mpox Patients and Vaccine Recipients
Authors not listed
Institute of Tropical Medicine, Belgium · 2022
Abstract
The goal of this observational study is to describe possible physical and psychological sequelae after an mpox infection and to evaluate the longevity of B- and T-cell immune responses in former mpox patients and vaccine recipients.
The main questions it aims to answer are:
* Are there any physical or pschological sequelae after mpox infection?
* Is the humoral and/or cellular immune response to MPOX (or vaccinia) virus) durable?
* Do the patients develop strong local immunity in comparison to systemic immunity?
* How long is the virus still detectable in semen, saliva or the ano-rectal region?
Participants will answer a questionnaire, samples with blood, saliva and semen as well as anal swabs will be collected. Follow-up visits 8, 16 and 24, 36, 48, and 60 months after infection or vaccination are planned.
A healthy control group will be recruited in our HIV-PrEP clinic.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-13 MST
Cite this
APA
Anonymous. (2022). Prospective On-site and Questionnaire Study for the FOLLOW-UP of Mpox Cohort at ITM PLUS Evaluation of the Longevity of B- and T-cell Immune Responses in Former Mpox Patients and Vaccine Recipients. <em>Institute of Tropical Medicine, Belgium</em>. https://clinicaltrials.gov/study/NCT05879965
Vancouver
Anonymous. Prospective On-site and Questionnaire Study for the FOLLOW-UP of Mpox Cohort at ITM PLUS Evaluation of the Longevity of B- and T-cell Immune Responses in Former Mpox Patients and Vaccine Recipients. Institute of Tropical Medicine, Belgium. 2022.
BibTeX
@misc{anon2022Prospe,
title = {Prospective On-site and Questionnaire Study for the FOLLOW-UP of Mpox Cohort at ITM PLUS Evaluation of the Longevity of B- and T-cell Immune Responses in Former Mpox Patients and Vaccine Recipients},
author = {Anonymous},
journal = {Institute of Tropical Medicine, Belgium},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
National Yang Ming Chiao Tung University 2026
Open access · US-GOV
Exploring the Association Between Intrinsic Capacity and Meaning in Life Among Middle-Aged and Older Adults in Community Centers
Vastra Gotaland Region 2020
Open access · US-GOV
The Sahlgrenska Anti-VEGF (SAHLVE) Study - a Prospective Randomized Double-blind Comparison of Bevacizumab and Aflibercept in Patients With Neovascular Age-related Macular Degeneration
Skyline Therapeutics 2025
Open access · US-GOV
A Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With Neovascular (Wet) Age-related Macular Degeneration (nAMD)
Istituto Nazionale di Ricovero e Cura per Anziani 2020
Open access · US-GOV
ReportAge-COVID Project: Clinical and Biological Predictors of COVID-19 Disease in Older Patients
Rudolf Foundation Clinic 2009
Open access · US-GOV
Impact of Visceral Fat on the Pathogenesis of Age-related Macular Degeneration
Radboud University Medical Center 2024
Open access · US-GOV